Epigenetic Mechanisms of Rubinstein–Taybi Syndrome

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuromolecular medicine

• Publication date

  2014-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12017-013-8285-3PMID 24381114PMCID PMC3948208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Journal of Medical Genetics Part A: Volume 167A, Number 11, November 2015.

  2015cited by this paper
• New CBP mutations in Brazilian patients with Rubinstein–Taybi syndrome

  2013cited by this paper
• Duplication 16p13.3 and the CREBBP gene: confirmation of the phenotype.

  2013cited by this paper
• Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca2+ signaling in Huntington’s disease

  2013cited by this paper
• An Essential Role for Histone Deacetylase 4 in Synaptic Plasticity and Memory Formation

  2012cited by this paper
• Cooperation of p300 and PCAF in the Control of MicroRNA 200c/141 Transcription and Epithelial Characteristics

  2012cited by this paper
• Rubinstein-Taybi syndrome: Clinical profile of 11 patients and review of literature

  2012cited by this paper
• The association of neural axis and craniovertebral junction anomalies with scoliosis in Rubinstein–Taybi syndrome

  2012cited by this paper
• Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.

  2012cited by this paper
• Age‐dependent change in behavioral feature in Rubinstein‐Taybi syndrome

  2012cited by this paper
• HDAC inhibition modulates hippocampus-dependent long-term memory for object location in a CBP-dependent manner.

  2011cited by this paper
• Regulation of immune cell function and differentiation by the NKG2D receptor

  2011cited by this paper
• A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.

  2011cited by this paper
• CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer

  2010cited by this paper
• Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.

  2009cited by this paper
• Modulation of long-term memory for object recognition via HDAC inhibition

  2009cited by this paper
• Psychiatric Profile in Rubinstein-Taybi Syndrome

  2009cited by this paper
• Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation.

  2008cited by this paper
• Duplication of the Rubinstein–Taybi region on 16p13.3 is associated with a distinctive phenotype

  2008cited by this paper
• Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

  2008cited by this paper
• Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

  2008cited by this paper
• Rubinstein–Taybi syndrome: clinical and molecular overview

  2007cited by this paper
• Genetic heterogeneity in Rubinstein–Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300

  2007cited by this paper
• Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation

  2007cited by this paper
• Epigenetics – A Science of Heritable Biological Adaptation

  2007cited by this paper
• Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction

  2006cited by this paper
• Screening for Partial Deletions in the CREBBP Gene in Rubinstein–Taybi Syndrome Patients Using Multiplex PCR/Liquid Chromatography

  2006cited by this paper
• ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease

  2006cited by this paper
• Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage.

  2005cited by this paper
• Rubinstein-Taybi syndrome: clinical and molecular cytogenetic studies.

  2005cited by this paper
• Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

  2005cited by this paper
• Sodium phenylbutyrate prolongs survival and regulates expression of anti‐apoptotic genes in transgenic amyotrophic lateral sclerosis mice

  2005cited by this paper
• The NRSE smRNA specifies the fate of adult hippocampal neural stem cells.

  2005cited by this paper
• A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis.

  2005cited by this paper
• Rubinstein–Taybi syndrome

  2005cited by this paper
• Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease*

  2005cited by this paper
• Benefit of valproic acid in suppressing disease progression of ALS model mice

  2004cited by this paper
• Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

  2004cited by this paper
• CBP histone acetyltransferase activity is a critical component of memory consolidation.

  2004cited by this paper
• Chemotherapy for the Brain: The Antitumor Antibiotic Mithramycin Prolongs Survival in a Mouse Model of Huntington's Disease

  2004cited by this paper
• Analysis of CBP (CREBBP) gene deletions in Rubinstein‐Taybi syndrome patients using real‐time quantitative PCR

  2004cited by this paper
• A 15‐Year‐Old Boy with Rubinstein‐Taybi Syndrome Associated with Severe Congenital Malalignment of the Toenails

  2004cited by this paper
• p300/CBP and cancer

  2004cited by this paper
• Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.

  2003cited by this paper
• Rubinstein‐Taybi syndrome medical guidelines

  2003cited by this paper
• Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications

  2003cited by this paper
• Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

  2003cited by this paper
• A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4

  2003cited by this paper
• Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration

  2003cited by this paper
• Review Histone Methylation: Dynamic or Static?

  2002cited by this paper
• Histone methylation: dynamic or static?

  2002cited by this paper
• The PHD Type Zinc Finger Is an Integral Part of the CBP Acetyltransferase Domain

  2002cited by this paper
• Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM.

  2002cited by this paper
• Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome

  2002cited by this paper
• p300/CBP/p53 interaction and regulation of the p53 response.

  2001cited by this paper
• [Dermatological stigmata in Rubinstein-Taybi syndrome].

  2001cited by this paper
• Dual Role of p300 in the Regulation of p53 Stability*

  2001cited by this paper
• Dermatologische Stigmata beim Rubinstein-Taybi-Syndrom

  2001cited by this paper
• Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome.

  2000cited by this paper
• Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

  2000cited by this paper
• Role for p300 in Stabilization of p53 in the Response to DNA Damage*

  1999cited by this paper
• Function for p300 and not CBP in the apoptotic response to DNA damage

  1999cited by this paper
• Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis.

  1999cited by this paper
• FISH studies in 45 patients with Rubinstein-Taybi syndrome: deletions associated with polysplenia, hypoplastic left heart and death in infancy

  1999cited by this paper
• DNA damage activates p53 through a phosphorylation-acetylation cascade.

  1998cited by this paper
• Rubinstein-Taybi syndrome. Review of 732 cases and analysis of the typical traits.

  1998cited by this paper
• The MAPK cascade is required for mammalian associative learning

  1998cited by this paper
• p300/MDM2 complexes participate in MDM2-mediated p53 degradation.

  1998cited by this paper
• Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome.

  1997cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• Submicroscopic deletions at 16p13.3 in Rubinstein-Taybi syndrome: frequency and clinical manifestations in a North American population.

  1997cited by this paper
• Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory.

  1997cited by this paper
• Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3.

  1997cited by this paper
• CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression.

  1996cited by this paper
• Tumors in Rubinstein-Taybi syndrome.

  1995cited by this paper
• Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

  1995cited by this paper
• Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects.

  1993cited by this paper
• [Rubinstein-Taybi syndrome in 4 cases].

  1990cited by this paper
• Rubinstein-Taybi syndrome: case report.

  1989cited by this paper
• [Oto-palato-digital syndrome. Clinico-radiological study].

  1987cited by this paper
• [The Rubinstein-Taybi syndrome].

  1971cited by this paper
• Oto-palato-digital syndrome.

  1967cited by this paper
• Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome.

  1963cited by this paper

• Клиническая и молекулярно-генетическая характеристика серии случаев синдрома Флоатинг-Харбор

  2025cites this paper
• Epigenetic Mechanisms Shaping Spine Regulation: Unveiling the Role of Cytoskeletal Dynamics and Localized Protein Synthesis

  2025cites this paper
• Prediction of New Nε-Acetylation Sites in the Human Proteome Based on Molecular Multilevel Neighborhoods of Atom Descriptors

  2025cites this paper
• An unusual presentation of glaucoma in a neonate with Rubinstein-Taybi syndrome

  2024cites this paper
• Epigenetic regulators controlling osteogenic lineage commitment and bone formation.

  2024cites this paper
• Epigenetics in rare neurological diseases

  2024influential citation
• Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review

  2024cites this paper
• Unlocking Plant Chemical Diversity: Exploring Epigenetic Influences on Secondary Metabolite Production

  2024cites this paper
• Molecular-genetic basis of Rubinstein–Taybi syndrome

  2023cites this paper
• Epigenetics and the evolution of form: Experimental manipulation of a chromatin modification causes species‐specific changes to the craniofacial skeleton

  2023cites this paper
• Genotype-phenotype analysis of ocular findings in Rubinstein-Taybi syndrome – A case report and review of literature

  2023cites this paper
• Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome

  2022cites this paper
• Menke–Hennekam Syndrome: A Literature Review and a New Case Report

  2022cites this paper
• Rubinstein–Taybi Syndrome in a Filipino Infant with a Novel CREBBP Gene Pathogenic Variant

  2022cites this paper
• A guide for the diagnosis of rare and undiagnosed disease: beyond the exome

  2022cites this paper
• Impaired Regulation of Histone Methylation and Acetylation Underlies Specific Neurodevelopmental Disorders

  2021cites this paper
• The development of early social cognitive skills in neurogenetic syndromes associated with autism: Cornelia de Lange, fragile X and Rubinstein–Taybi syndromes

  2021cites this paper
• CRISPR/Cas9 in epigenetics studies of health and disease.

  2021cites this paper
• Rubinstein-Taybi syndrome with scoliosis treated with single-stage posterior spinal fusion: illustrative case

  2021cites this paper
• Histone deacetylase in neuropathology.

  2021cites this paper
• Binding mechanism, conformation, and stability of diflunisal and mycophenolic acid with p300 HAT enzyme using molecular dynamics simulation and binding free energy analysis

  2020cites this paper
• HAT inhibitors in cancer therapy

  2020cites this paper
• An Observational Study of Social Interaction Skills and Behaviors in Cornelia de Lange, Fragile X and Rubinstein-Taybi Syndromes

  2020cites this paper
• Rubinstein-Taybi Syndrome

  2020cites this paper
• KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies

  2020cites this paper
• Histone Acetyltransferase Enzymes: From Biological Implications to Most Relevant Inhibitors

  2019cites this paper
• BRPF1‐associated intellectual disability, ptosis, and facial dysmorphism in a multiplex family

  2019cites this paper
• Potential epigenomic co-management in rare diseases and epigenetic therapy

  2019cites this paper
• A new missense mutation in DPF2 gene related to Coffin Siris syndrome 7: Description of a mild phenotype expanding DPF2-related clinical spectrum and differential diagnosis among similar syndromes epigenetically determined.

  2019cites this paper
• Social cognition in genetic syndromes

  2018influential citation
• iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability.

  2018cites this paper
• Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer

  2018cites this paper
• Targeting Phytochemical Driver in AC/cAMP/PKA/CREB Activation: The Next Frontier for Alleviating Huntington’s Type Neurodegenerative Disorders in 3-NP Animal Model: A Complete Review

  2017cites this paper
• Rubinstein-Taybi Syndrome Associated with Pituitary Macroadenoma: A Case Report

  2017cites this paper
• Recent advances in congenital heart disease genomics

  2017cites this paper
• Characterisation of the gene PTPRS in the development of the cerebral cortex

  2017cites this paper
• Co‐administration of ginseng and ciprofloxacin ameliorates epididymo‐orchitis induced alterations in sperm quality and spermatogenic cells apoptosis following infection in rats

  2017cites this paper
• Implications of de novo mutations in guiding drug discovery: A study of four neuropsychiatric disorders

  2017cites this paper
• Epigenetic dysfunctional diseases and therapy for infection and inflammation.

  2017cites this paper
• Epigenetics in Rare Diseases

  2017cites this paper
• The right time to learn: mechanisms and optimization of spaced learning

  2016cites this paper
• Epigenetic biomarkers: New findings, perspectives and future directions in diagnostics

  2016cites this paper
• Hepatoblastoma in Rubinstein–Taybi Syndrome: A Case Report

  2016cites this paper
• From Whole Gene Deletion to Point Mutations of EP300‐Positive Rubinstein–Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks

  2016cites this paper
• Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors

  2016cites this paper
• Histone Modification in Osteogenic Differentiation of Skeletal Stem Cells.

  2015cites this paper
• Ultra-Rare Syndromes: The Example of Rubinstein–Taybi Syndrome

  2015cites this paper
• Characterization of 14 novel deletions underlying Rubinstein–Taybi syndrome: an update of the CREBBP deletion repertoire

  2015cites this paper
• Role of nucleosome remodeling in neurodevelopmental and intellectual disability disorders

  2015cites this paper
• Prospects for the development of epigenetic drugs for CNS conditions

  2015cites this paper
• Insights into genotype–phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein–Taybi syndrome patients

  2015cites this paper
• Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

  2015cites this paper
• Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management

  2015cites this paper
• SÍNDROME DE RUBINSTEIN-TAYBI: NOVA MUTAÇÃO

  2014cites this paper
• The regulation of transcription in memory consolidation.

  2014cites this paper
• Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology.

  2014cites this paper
• Epigenetic factors in intellectual disability: the Rubinstein-Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin.

  2014cites this paper
• Simulations suggest pharmacological methods for rescuing long-term potentiation.

  2014influential citation